Technical Analysis for INSY - Insys Therapeutics, Inc.

Grade Last Price % Change Price Change
grade A 8.91 -2.20% -0.20
INSY closed down 2.2 percent on Friday, October 19, 2018, on 32 percent of normal volume.

Earnings due: Nov 1

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Up Up Flat
See historical INSY trend table...

Date Alert Name Type % Chg
Oct 19 20 DMA Resistance Bearish 0.00%
Oct 19 Outside Day Range Expansion 0.00%
Oct 18 20 DMA Resistance Bearish -2.20%
Oct 18 NR7 Range Contraction -2.20%
Oct 18 Inside Day Range Contraction -2.20%
Oct 17 20 DMA Resistance Bearish -4.40%
Oct 17 Doji - Bearish? Reversal -4.40%
Oct 16 20 DMA Resistance Bearish -4.40%
Oct 16 50 DMA Support Bullish -4.40%
Oct 16 180 Bullish Setup Bullish Swing Setup -4.40%

Older signals for INSY ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
INSYS Therapeutics, Inc., a development stage company, develops pharmaceutical products that target the unmet needs of cancer patients, with a focus on cancer-supportive care. The company's cancer-supportive care and cancer therapy product candidates include Fentanyl sublingual spray, a single-use product for the treatment of breakthrough cancer pain; and Dronabinol SG capsule, an ANDA approved product and Dronabinol Oral Solution, which completed Phase II clinical trials for the treatment of chemotherapy-induced nausea and vomiting, and appetite stimulation in AIDS patients. It also develops proprietary cancer therapeutics comprising LEP-ETU, a NeoLipid liposomal, which is in Phase II clinical development stage to enhance efficacy and reduce paclitaxel-related side effects. The company was founded in 2002 and is based in Phoenix, Arizona.
Is INSY a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 4 bullish, 0 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 14.0
52 Week Low 4.1
Average Volume 894,769
200-Day Moving Average 7.775
50-Day Moving Average 8.7251
20-Day Moving Average 9.333
10-Day Moving Average 8.926
Average True Range 0.5803
ADX 30.52
+DI 18.2351
-DI 15.2156
Chandelier Exit (Long, 3 ATRs ) 8.6991
Chandelier Exit (Short, 3 ATRs ) 10.1509
Upper Bollinger Band 10.3126
Lower Bollinger Band 8.3534
Percent B (%b) 0.28
BandWidth 20.992178
MACD Line 0.0446
MACD Signal Line 0.1156
MACD Histogram -0.071
Fundamentals Value
Market Cap 647.73 Million
Num Shares 72.7 Million
EPS -0.22
Price-to-Earnings (P/E) Ratio -40.50
Price-to-Sales 2.18
Price-to-Book 1.57
PEG Ratio -0.62
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 9.79
Resistance 3 (R3) 9.85 9.62 9.64
Resistance 2 (R2) 9.62 9.40 9.59 9.59
Resistance 1 (R1) 9.27 9.26 9.15 9.20 9.54
Pivot Point 9.04 9.04 8.98 9.01 9.04
Support 1 (S1) 8.68 8.81 8.57 8.62 8.28
Support 2 (S2) 8.45 8.68 8.42 8.23
Support 3 (S3) 8.10 8.45 8.18
Support 4 (S4) 8.03